We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$251M
AUM Growth
+$5.09M
Cap. Flow
-$15.3M
Cap. Flow %
-6.09%
Top 10 Hldgs %
39.13%
Holding
93
New
1
Increased
10
Reduced
55
Closed
4

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$484K
2
XYL icon
Xylem
XYL
+$262K
3
ALLE icon
Allegion
ALLE
+$182K
4
HD icon
Home Depot
HD
+$173K
5
AMZN icon
Amazon
AMZN
+$116K

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$1.93M
2
CVS icon
CVS Health
CVS
+$1.59M
3
ILMN icon
Illumina
ILMN
+$1.19M
4
NVDA icon
NVIDIA
NVDA
+$1.1M
5
DHR icon
Danaher
DHR
+$781K

Sector Composition

Rank Sector Weight
1 Technology 29.51%
2 Healthcare 22.52%
3 Industrials 13.22%
4 Consumer Discretionary 9.05%
5 Consumer Staples 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVS icon
26
Novartis
NVS
$297B
$3.71M 1.48%
36,731
-5,320
-13% -$514K
BDX icon
27
Becton Dickinson
BDX
$43.8B
$3.25M 1.3%
13,314
+133
+1% +$32.8K
NKE icon
28
Nike
NKE
$62.5B
$2.9M 1.16%
26,726
+125
+0.5% +$13.4K
LOW icon
29
Lowe's Companies
LOW
$119B
$2.6M 1.04%
11,670
ACN icon
30
Accenture
ACN
$94.3B
$2.3M 0.92%
6,549
-330
-5% -$106K
MDT icon
31
Medtronic
MDT
$108B
$2.2M 0.88%
26,686
+260
+1% +$19.8K
JPM icon
32
JPMorgan Chase
JPM
$947B
$2.18M 0.87%
12,817
-1,250
-9% -$189K
CVX icon
33
Chevron
CVX
$378B
$2.18M 0.87%
14,605
+40
+0.3% +$6.05K
SYK icon
34
Stryker
SYK
$129B
$2.03M 0.81%
6,770
-1,220
-15% -$342K
MRK icon
35
Merck
MRK
$323B
$1.78M 0.71%
16,350
-1,550
-9% -$161K
COST icon
36
Costco
COST
$422B
$1.71M 0.68%
2,598
ECL icon
37
Ecolab
ECL
$76.4B
$1.67M 0.67%
8,430
-220
-3% -$39.6K
ADBE icon
38
Adobe
ADBE
$94.5B
$1.59M 0.63%
2,660
ITW icon
39
Illinois Tool Works
ITW
$81.9B
$1.56M 0.62%
5,943
-520
-8% -$125K
UNP icon
40
Union Pacific
UNP
$178B
$1.5M 0.6%
6,110
-1,160
-16% -$255K
CVS icon
41
CVS Health
CVS
$137B
$1.47M 0.58%
18,562
-22,309
-55% -$1.59M
AMGN icon
42
Amgen
AMGN
$203B
$1.46M 0.58%
5,083
-600
-11% -$163K
HON icon
43
Honeywell
HON
$77.9B
$1.42M 0.57%
7,199
-2,562
-26% -$462K
ORCL icon
44
Oracle
ORCL
$345B
$1.37M 0.54%
12,950
-750
-5% -$81.9K
CHD icon
45
Church & Dwight Co
CHD
$23.4B
$1.25M 0.5%
13,260
-3,490
-21% -$319K
INTC icon
46
Intel
INTC
$462B
$1.24M 0.49%
24,620
-7,000
-22% -$284K
AVGO icon
47
Broadcom
AVGO
$1.82T
$1.21M 0.48%
10,800
EMR icon
48
Emerson Electric
EMR
$83.6B
$1.14M 0.46%
11,740
-1,402
-11% -$128K
NEE icon
49
NextEra Energy
NEE
$185B
$1.07M 0.43%
17,696
TT icon
50
Trane Technologies
TT
$107B
$1.05M 0.42%
4,300
-200
-4% -$43.8K

Similar funds

Notis-McConarty Edward's Q4 2023 Portfolio in Review

As of Q4 2023, Notis-McConarty Edward held 93 positions worth $251M, up 2.1% from $246M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Notis-McConarty Edward withdrew a net $15.3M in Q4 2023, closing 4 positions and reducing 55 holdings. Its most notable exit was Walt Disney, an estimated $1.93M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Notis-McConarty Edward opened a new position in Allegion worth $215K.

  • Notis-McConarty Edward's largest Q4 2023 buy was Allegion: 1,700 shares worth $215K.
  • Notis-McConarty Edward added most to UnitedHealth in Q4 2023, an estimated $484K increase.
  • Notis-McConarty Edward's biggest Q4 2023 reduction was CVS Health, cutting an estimated $1.59M.
  • Notis-McConarty Edward fully exited Walt Disney in Q4 2023, selling an estimated $1.93M.
  • Notis-McConarty Edward's ten largest holdings make up 39% of its $251M portfolio in Q4 2023.
  • Notis-McConarty Edward opened 1 new position and closed 4 in Q4 2023.
  • Notis-McConarty Edward's portfolio value rose 2.1% quarter-over-quarter to $251M.

Based on Notis-McConarty Edward's 13F filing for Q4 2023, filed 14 Feb 2024.